Doctor leaned on a window, looking outside

How can the Teva IMPACT-TD Registry help us better understand our patients?

About the Registry

The Teva IMPACT-TD Registry will follow patients for 3 years and will investigate how TD progresses over time and evaluate the impact of TD on patients’ lives
This information – gathered via questionnaires to be completed during the patient’s usual clinic visits – will answer key questions that will help illustrate the full impact of TD, such as:
- How and to what extent TD affects a person’s life
- How and when to assess impact and how to measure improvement
- How does the impact of TD change over time
- When TD can be considered ‘disabling’, as stated in the APA Guidelines

Patient eligibility

Help us by enrolling patients who

Are 18 years of age or older, with capacity to provide informed consent
Have an Abnormal Involuntary Movement Scale (AIMS) score of ≥2 in at least one body region and probable TD based on DSM-5 criteria

Or patients who

Are 18 years of age or older, with capacity to provide informed consent
Are on stable treatment with a VMAT2 inhibitor

Register your interest in participating

If you are treating eligible patients and are interested in participating in the study, please enter your contact information below and a study representative will contact you to discuss further

First name: (required)

Last name: (required)

Name of site: (required)

City: (required)

State: (required)

Preferred contact number: (required)

Preferred callback time: (morning/ afternoon/ evening)